{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:49:35Z","timestamp":1762480175057,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"am","delay-in-days":391,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaesthesia Critical Care & Pain Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.accpm.2020.03.008","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T11:44:17Z","timestamp":1583581457000},"page":"189-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should we ban hydroxyethyl starches from the operating theatre? CON, PRO or something else?"],"prefix":"10.1016","volume":"39","author":[{"given":"Laurent","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.accpm.2020.03.008_bib0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"German Competence Network S: Intensive insulin therapy and pentastarch resuscitation in severe sepsis","volume":"358","author":"Brunkhorst","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2020.03.008_bib0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1204242","article-title":"Scandinavian Critical Care Trials G: Hydroxyethyl starch 130\/0.42 versus Ringer's acetate in severe sepsis","volume":"367","author":"Perner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.accpm.2020.03.008_bib0135","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med"},{"year":"2013","series-title":"European Medical Agency: PRAC confirms that hydroxyethyl-starch solutions (HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients","key":"10.1016\/j.accpm.2020.03.008_bib0140"},{"key":"10.1016\/j.accpm.2020.03.008_bib0145","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/jama.2013.280502","article-title":"Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial","volume":"310","author":"Annane","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2020.03.008_bib0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/EJA.0000000000000328","article-title":"Comparison of hydroxyethyl starch colloids with crystalloids for surgical patients: a systematic review and meta-analysis","volume":"33","author":"Raiman","year":"2016","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.accpm.2020.03.008_bib0155","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/bja\/aew249","article-title":"Impact of balanced tetrastarch raw material on perioperative blood loss: a randomized double blind controlled trial","volume":"117","author":"Joosten","year":"2016","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.accpm.2020.03.008_bib0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/ALN.0000000000001936","article-title":"Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system: a randomized, double-blinded, controlled trial in major abdominal surgery","volume":"128","author":"Joosten","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2020.03.008_bib0165","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/ALN.0000000000002501","article-title":"Long-term impact of crystalloid versus colloid solutions on renal function and disability-free survival after major abdominal surgery","volume":"130","author":"Joosten","year":"2019","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2020.03.008_bib0170","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0140-6736(18)30254-X","article-title":"EMA recommendation to suspend HES is hazardous","volume":"391","author":"Annane","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.accpm.2020.03.008_bib0175","doi-asserted-by":"crossref","first-page":"k1287","DOI":"10.1136\/bmj.k1287","article-title":"EMA recommendation on hydroxyethyl starch solutions obscured controversy","volume":"360","author":"Doshi","year":"2018","journal-title":"BMJ"},{"year":"2018","series-title":"EMA EMA: Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients. Medicines to remain on the market provided that training, controlled access and warnings on the packaging are implemented","key":"10.1016\/j.accpm.2020.03.008_bib0180"},{"key":"10.1016\/j.accpm.2020.03.008_bib0185","doi-asserted-by":"crossref","unstructured":"Degoul S, Chazard E, Lamer A, Lebuffe G, Duhamel A, Tavernier B. lntraoperative administration of 6% hydroxyethyl starch 130\/0.4 is not associated with acute kidney injury in elective non-cardiac surgery: a sequential and propensity-matched analysis. Anaesth Crit. Care Pain Med. Doi: https:\/\/doi.org\/10.1016\/j.accpm.2019.08.002","DOI":"10.1016\/j.accpm.2019.08.002"},{"key":"10.1016\/j.accpm.2020.03.008_bib0190","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jama.2019.20833","article-title":"Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH Randomized Clinical Trial","volume":"323","author":"Futier","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2020.03.008_bib0195","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jama.2013.430","article-title":"Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis","volume":"309","author":"Zarychanski","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.accpm.2020.03.008_bib0200","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00134-013-2840-0","article-title":"Fluid resuscitation with 6% hydroxyethyl starch (130\/0.4 and 130\/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy","volume":"39","author":"Gattas","year":"2013","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2020.03.008_bib0205","doi-asserted-by":"crossref","first-page":"f839","DOI":"10.1136\/bmj.f839","article-title":"Hydroxyethyl starch 130\/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis","volume":"346","author":"Haase","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.accpm.2020.03.008_bib0210","first-page":"CD007594","article-title":"Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function","author":"Mutter","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"185","key":"10.1016\/j.accpm.2020.03.008_bib0215","first-page":"e1","article-title":"Fluid resuscitation with hydroxyethyl starches in patients with sepsis is associated with an increased incidence of acute kidney injury and use of renal replacement therapy: a systematic review and meta-analysis of the literature","volume":"29","author":"Serpa Neto","year":"2014","journal-title":"J Crit Care"},{"key":"10.1016\/j.accpm.2020.03.008_bib0220","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00134-015-3794-1","article-title":"Fluid type and the use of renal replacement therapy in sepsis: a systematic review and network meta-analysis","volume":"41","author":"Rochwerg","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.accpm.2020.03.008_bib0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13054-015-0833-9","article-title":"Hydroxyethyl starch versus other fluids for non-septic patients in the intensive care unit: a meta-analysis of randomized controlled trials","volume":"19","author":"He","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.accpm.2020.03.008_bib0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jcrc.2018.11.031","article-title":"Crystalloids vs. colloids for fluid resuscitation in the intensive care unit: a systematic review and meta-analysis","volume":"50","author":"Martin","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.accpm.2020.03.008_bib0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/ALN.0b013e31827e5569","article-title":"Effect of waxy maize-derived hydroxyethyl starch 130\/0.4 on renal function in surgical patients","volume":"118","author":"Martin","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.accpm.2020.03.008_bib0240","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/bja\/aet303","article-title":"Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis","volume":"112","author":"Gillies","year":"2014","journal-title":"Br J Anaesth"}],"container-title":["Anaesthesia Critical Care & Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556820300400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352556820300400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:44:44Z","timestamp":1762479884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352556820300400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2352556820300400"],"URL":"https:\/\/doi.org\/10.1016\/j.accpm.2020.03.008","relation":{},"ISSN":["2352-5568"],"issn-type":[{"type":"print","value":"2352-5568"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should we ban hydroxyethyl starches from the operating theatre? CON, PRO or something else?","name":"articletitle","label":"Article Title"},{"value":"Anaesthesia Critical Care & Pain Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.accpm.2020.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise d'anesth\u00e9sie et de r\u00e9animation (Sfar).","name":"copyright","label":"Copyright"}]}}